RECRUITING

MRI Screening in Men at High Risk of Developing Prostate Cancer

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to determine whether or not Magnetic Resonance Images (MRI) will identify high-grade cancers earlier and more frequently in men at high risk of developing prostate cancer.

Official Title

MRI Screening in Men at High Risk of Developing Prostate Cancer

Quick Facts

Study Start:2022-03-02
Study Completion:2039-03-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05608694

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:MALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Male age 18 and older
  2. * No known history of prostate cancer
  3. * No previous prostate resection or ablation (e.g. TURP, photovaporization)
  1. * Unable to tolerate MRI due to metal fragments or claustrophobia
  2. * Lack of a rectum
  3. * Hip arthroplasty

Contacts and Locations

Study Contact

Scott Eggener, MD
CONTACT
7737021001
seggener@surgery.bsd.uchicago.edu
Teresa Barry
CONTACT
tbarry@bsd.uchicago.edu

Principal Investigator

Scott Eggener, MD
PRINCIPAL_INVESTIGATOR
University of Chicago

Study Locations (Sites)

University of Chicago
Chicago, Illinois, 60637
United States
NorthShore University Health System - Glenbrook Hospital
Glenview, Illinois, 60026
United States

Collaborators and Investigators

Sponsor: University of Chicago

  • Scott Eggener, MD, PRINCIPAL_INVESTIGATOR, University of Chicago

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-03-02
Study Completion Date2039-03-01

Study Record Updates

Study Start Date2022-03-02
Study Completion Date2039-03-01

Terms related to this study

Additional Relevant MeSH Terms

  • Prostate Cancer Screening